IDO1 is defective in DCs of non-obese diabetic (NOD) mice (42), an experimental model of human autoimmune diabetes (type 1 diabetes or T1D), and maneuvers aimed at enhancing its expression and activity will exert therapeutic effects in prediabetic and also overtly diabetic animals (43, 44). Here, IDO1 is linked to type 1 diabetes mellitus.